{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:07:50Z","timestamp":1787062070105,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.nucmedbio.2024.108968","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T01:41:29Z","timestamp":1731030089000},"page":"108968","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Brain drug delivery from the nasal olfactory region is enhanced using lauroylcholine chloride: An estimation using in vivo PET imaging"],"prefix":"10.1016","volume":"138-139","author":[{"given":"Shota","family":"Fukakusa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiya","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Haruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Magata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2024.108968_bb0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0015","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuroscience.2008.01.013","article-title":"Delivery of interferon-beta to the monkey nervous system following intranasal administration","volume":"152","author":"Thorne","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/10717544.2013.838713","article-title":"Insights into direct nose to brain delivery: current status and future perspective","volume":"21","author":"Mittal","year":"2014","journal-title":"Drug Deliv"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0025","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111904","article-title":"Selective CNS targeting and distribution with a refined region-specific intranasal delivery technique via the olfactory mucosa","volume":"13","author":"Maigler","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14051026","article-title":"Indirect SPECT imaging evaluation for possible nose-to-brain drug delivery using a compound with poor blood-brain barrier permeability in mice","volume":"14","author":"Mizutani","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0040","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jconrel.2023.06.005","article-title":"Effective nose-to-brain drug delivery using a combination system targeting the olfactory region in monkeys","volume":"359","author":"Sasaki","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0045","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1080\/10717544.2020.1837291","article-title":"Direct nose to brain delivery of small molecules: critical analysis of data from a standardized in vivo screening model in rats","volume":"27","author":"Dhuyvetter","year":"2020","journal-title":"Drug Deliv"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0050","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.colsurfb.2017.03.035","article-title":"Nose to brain delivery in rats: effect of surface charge of rhodamine B labeled nanocarriers on brain subregion localization","volume":"154","author":"Bonaccorso","year":"2017","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111745","article-title":"Investigation of the transport pathways associated with enhanced brain delivery of peptide drugs by intranasal coadministration with penetratin","volume":"13","author":"Kamei","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijpharm.2018.05.029","article-title":"The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs","volume":"547","author":"Dahlgren","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(99)00100-3","article-title":"Screening of cationic compounds as an absorption enhancer for nasal drug delivery","volume":"185","author":"Natsume","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0168-3659(87)90072-1","article-title":"Absorption enhancing agents for the GI system","volume":"6","author":"Fix","year":"1987","journal-title":"J Control Release"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1162\/153535003322556877","article-title":"AMIDE: a free software tool for multimodality medical image analysis","volume":"2","author":"Loening","year":"2003","journal-title":"Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0080","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/(SICI)1099-1344(199912)42:12<1183::AID-JLCR274>3.0.CO;2-Z","article-title":"Precursor synthesis and radiolabelling of the dopamine D2 receptor ligand [11C]raclopride from [11C]methyl triflate","volume":"42","author":"Langer","year":"1999","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0085","doi-asserted-by":"crossref","first-page":"7148","DOI":"10.1088\/1361-6560\/aa82e8","article-title":"Performance evaluation of a high-resolution brain PET scanner using four-layer MPPC DOI detectors","volume":"62","author":"Watanabe","year":"2017","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0090","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.neuroimage.2014.04.001","article-title":"Waxholm space atlas of the Sprague Dawley rat brain","volume":"97","author":"Papp","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0095","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00004647-199609000-00008","article-title":"Distribution volume ratios without blood sampling from graphical analysis of PET data","volume":"16","author":"Logan","year":"1996","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0100","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejpb.2019.04.002","article-title":"Pharmacological characterization of the 3D MucilAir\u2122 nasal model","volume":"139","author":"Mercier","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12010079","article-title":"Comparison of various cell lines and three-dimensional Mucociliary tissue model systems to estimate drug permeability using an in vitro transport study to predict nasal drug absorption in rats","volume":"12","author":"Furubayashi","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.105022","article-title":"Evaluation of the toxicity of sodium dodecyl sulphate (SDS) in the MucilAir\u2122 human airway model in vitro","volume":"125","author":"Welch","year":"2021","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0115","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/03639045.2012.692376","article-title":"The effect of various absorption enhancers on tight junction in the human intestinal Caco-2 cell line","volume":"39","author":"Yu","year":"2013","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0120","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/jps.10559","article-title":"Assessment of the effects of sodium dodecyl sulfate on the buccal permeability of caffeine and estradiol","volume":"93","author":"Nicolazzo","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0125","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1007\/s00259-016-3476-4","article-title":"Guidelines to PET measurements of the target occupancy in the brain for drug development","volume":"43","author":"Takano","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/AAC.39.1.50","article-title":"Long-chain alkanoylcholines, a new category of soft antimicrobial agents that are enzymatically degradable","volume":"39","author":"Ahlstr\u00f6m","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0135","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1172\/JCI118699","article-title":"P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs","volume":"97","author":"Schinkel","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nucmedbio.2024.108968_bb0140","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1021\/acs.molpharmaceut.5b00103","article-title":"Microarray determination of the expression of drug transporters in humans and animal species used for the investigation of nasal absorption","volume":"12","author":"Al-Ghabeish","year":"2015","journal-title":"Mol Pharm"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805124000945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805124000945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T22:48:19Z","timestamp":1734648499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805124000945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":28,"alternative-id":["S0969805124000945"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108968","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain drug delivery from the nasal olfactory region is enhanced using lauroylcholine chloride: An estimation using in vivo PET imaging","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108968","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108968"}}